Complicated pneumococcal pneumonia in adults

E. Polverino, C. Cilloniz, C. Esquinas, J. A. Riesco, J. Mensa, M. A. Marcos, E. Bragulat, R. Menendez, A. Torres (Barcelona, Valencia, Spain)

Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Polverino, C. Cilloniz, C. Esquinas, J. A. Riesco, J. Mensa, M. A. Marcos, E. Bragulat, R. Menendez, A. Torres (Barcelona, Valencia, Spain). Complicated pneumococcal pneumonia in adults. Eur Respir J 2009; 34: Suppl. 53, 2386

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Severe complicated pneumococcal pneumonia in young adults
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Complicated pneumonia in children
Source: Breathe 2013; 9: 210-222
Year: 2013

Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006



Absence of leukocytosis in bacteremic pneumococcal pneumonia
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

The pathophysiology of pneumococcal pneumonia
Source: Eur Respir Monogr 2014; 63: 42-63
Year: 2014


Role of pneumococcal vaccine on the incidence of childhood empyema
Source: Breathe 2010; 6: 366-367
Year: 2010

Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
Source: Virtual Congress 2021 – Pneumonia
Year: 2021


The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



Influence of comorbidities on pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012

Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Preventing community-acquired pneumonia
Source: International Congress 2019 – Respiratory infections: prevention is better than cure
Year: 2019


Necrotising pneumonia in children
Source: Annual Congress 2007 - Why is complicated pneumonia and empyema increasing so rapidly in children?
Year: 2007


Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003


Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013




Particularities of community-acquired pneumonia in the elderly
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007


Severe community-acquired pneumonia
Source: Eur Respir Monogr 2016; 74: 101-116
Year: 2016